OREBRIEF · SOURCE REPORT
Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
Source: Newsfile · Reported October 2, 2026 · VM
At a glance
Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that, further to the Company's news release dated September 24, 2026, the Company has completed its previously announced shares for debt settlement, in settlement of outstanding indebtedness in the aggregate amount of $192,300 (the...
From the available Newsfile headline and excerpt. Company claims have not been independently verified.
Read the source
Open the original report at Newsfile ↗Why this story is ranked here · 7/100
- Source excerpt available
Editorial priority, not an investment rating. This is the public ranking; personal watchlists can add a small boost in your feed. Methodology →